TUCKER, MIRIAM E.. "ACIP Crafts Plan For DTaP Shortage.(Brief Article)." Family Practice News. International Medical News Group. 2001. HighBeam Research. 19 May. 2013 <http://www.highbeam.com>.
TUCKER, MIRIAM E.. "ACIP Crafts Plan For DTaP Shortage.(Brief Article)." Family Practice News. 2001. HighBeam Research. (May 19, 2013). http://www.highbeam.com/doc/1G1-73180976.html
TUCKER, MIRIAM E.. "ACIP Crafts Plan For DTaP Shortage.(Brief Article)." Family Practice News. International Medical News Group. 2001. Retrieved May 19, 2013 from HighBeam Research: http://www.highbeam.com/doc/1G1-73180976.html
ATLANTA -- Infants receiving their first three doses of diphtheria-tetanus-acellular pertussis vaccine should be given first priority if a shortage of DTaP vaccine develops in the next few months, members decided at a meeting of the Centers for Disease Control and Prevention's Advisory Committee on Immunization Practices.
In late 2000, two of the four United States manufacturers of DTaP vaccine--Wyeth-Lederle and Baxter Hyland Immuno--announced that they were ceasing production of Acel-Imune and Certiva, respectively. That leaves just two DTaP vaccines licensed for the U.S. market: Aventis-Pasteur's Tripedia and Glaxo SmithKline's Infanrix.
There is no major shortage of DTaP currently, but the CDC's National Immunization Program is taking steps now to prioritize use of the vaccine in case the supply falls short in …
The Turkish Journal of Pediatrics; November 1, 2010
Nursing Education Perspectives; January 1, 2004
Human Resources for Health; July 31, 2007
Vaccine Weekly; July 6, 2011
CMAJ: Canadian Medical Association Journal; March 4, 2003
Browse back issues from our extensive library of more than 6,500 trusted publications.
Help us improve our websites
Become a member of our Customer Advisory Panel. Your opinion matters!Join the panel
HighBeam Research is operated by Cengage Learning. © Copyright 2013. All rights reserved.
The HighBeam advertising network includes: womensforum.com GlamFamily